 | • レポートコード：MRC2-11QY08832 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多年生アレルギー性鼻炎治療薬のグローバル市場について調査・分析したレポートです。種類別（APC-3000、アサピプラント、ビラスチン、デスロラタジン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多年生アレルギー性鼻炎治療薬の競争状況、市場シェア ・世界の多年生アレルギー性鼻炎治療薬市場：種類別市場規模 2015年-2020年（APC-3000、アサピプラント、ビラスチン、デスロラタジン、その他） ・世界の多年生アレルギー性鼻炎治療薬市場：種類別市場規模予測 2021年-2026年（APC-3000、アサピプラント、ビラスチン、デスロラタジン、その他） ・世界の多年生アレルギー性鼻炎治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の多年生アレルギー性鼻炎治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の多年生アレルギー性鼻炎治療薬市場分析：米国、カナダ ・ヨーロッパの多年生アレルギー性鼻炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多年生アレルギー性鼻炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多年生アレルギー性鼻炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多年生アレルギー性鼻炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Faes Farma, S.A.、Glenmark Pharmaceuticals Ltd.、Hisamitsu Pharmaceutical Co., Inc.、Merck & Co., Inc.、Pfizer Inc.、Shionogi & Co., Ltd.、VentiRx Pharmaceuticals, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Perennial Allergic Rhinitis Drug Market
The global Perennial Allergic Rhinitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Perennial Allergic Rhinitis Drug Scope and Market Size
Perennial Allergic Rhinitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Perennial Allergic Rhinitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Perennial Allergic Rhinitis Drug market is segmented into
APC-3000
Asapiprant
Bilastine
Desloratadine
Others
Segment by Application, the Perennial Allergic Rhinitis Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Perennial Allergic Rhinitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Perennial Allergic Rhinitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Perennial Allergic Rhinitis Drug Market Share Analysis
Perennial Allergic Rhinitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Perennial Allergic Rhinitis Drug business, the date to enter into the Perennial Allergic Rhinitis Drug market, Perennial Allergic Rhinitis Drug product introduction, recent developments, etc.
The major vendors covered:
Faes Farma, S.A.
Glenmark Pharmaceuticals Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Merck & Co., Inc.
Pfizer Inc.
Shionogi & Co., Ltd.
VentiRx Pharmaceuticals, Inc.
…
1 Study Coverage
1.1 Perennial Allergic Rhinitis Drug Product Introduction
1.2 Market Segments
1.3 Key Perennial Allergic Rhinitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Perennial Allergic Rhinitis Drug Market Size Growth Rate by Type
1.4.2 APC-3000
1.4.3 Asapiprant
1.4.4 Bilastine
1.4.5 Desloratadine
1.4.6 Others
1.5 Market by Application
1.5.1 Global Perennial Allergic Rhinitis Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Perennial Allergic Rhinitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Perennial Allergic Rhinitis Drug Revenue 2015-2026
2.1.2 Global Perennial Allergic Rhinitis Drug Sales 2015-2026
2.2 Global Perennial Allergic Rhinitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Perennial Allergic Rhinitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Perennial Allergic Rhinitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Perennial Allergic Rhinitis Drug Competitor Landscape by Players
3.1 Perennial Allergic Rhinitis Drug Sales by Manufacturers
3.1.1 Perennial Allergic Rhinitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Perennial Allergic Rhinitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Perennial Allergic Rhinitis Drug Revenue by Manufacturers
3.2.1 Perennial Allergic Rhinitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Perennial Allergic Rhinitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Perennial Allergic Rhinitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Perennial Allergic Rhinitis Drug Revenue in 2019
3.2.5 Global Perennial Allergic Rhinitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Perennial Allergic Rhinitis Drug Price by Manufacturers
3.4 Perennial Allergic Rhinitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Perennial Allergic Rhinitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Perennial Allergic Rhinitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Perennial Allergic Rhinitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Perennial Allergic Rhinitis Drug Market Size by Type (2015-2020)
4.1.1 Global Perennial Allergic Rhinitis Drug Sales by Type (2015-2020)
4.1.2 Global Perennial Allergic Rhinitis Drug Revenue by Type (2015-2020)
4.1.3 Perennial Allergic Rhinitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Perennial Allergic Rhinitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Perennial Allergic Rhinitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Perennial Allergic Rhinitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Perennial Allergic Rhinitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Perennial Allergic Rhinitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Perennial Allergic Rhinitis Drug Market Size by Application (2015-2020)
5.1.1 Global Perennial Allergic Rhinitis Drug Sales by Application (2015-2020)
5.1.2 Global Perennial Allergic Rhinitis Drug Revenue by Application (2015-2020)
5.1.3 Perennial Allergic Rhinitis Drug Price by Application (2015-2020)
5.2 Perennial Allergic Rhinitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Perennial Allergic Rhinitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Perennial Allergic Rhinitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Perennial Allergic Rhinitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Perennial Allergic Rhinitis Drug by Country
6.1.1 North America Perennial Allergic Rhinitis Drug Sales by Country
6.1.2 North America Perennial Allergic Rhinitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Perennial Allergic Rhinitis Drug Market Facts & Figures by Type
6.3 North America Perennial Allergic Rhinitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Perennial Allergic Rhinitis Drug by Country
7.1.1 Europe Perennial Allergic Rhinitis Drug Sales by Country
7.1.2 Europe Perennial Allergic Rhinitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Perennial Allergic Rhinitis Drug Market Facts & Figures by Type
7.3 Europe Perennial Allergic Rhinitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Perennial Allergic Rhinitis Drug by Region
8.1.1 Asia Pacific Perennial Allergic Rhinitis Drug Sales by Region
8.1.2 Asia Pacific Perennial Allergic Rhinitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Perennial Allergic Rhinitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Perennial Allergic Rhinitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Perennial Allergic Rhinitis Drug by Country
9.1.1 Latin America Perennial Allergic Rhinitis Drug Sales by Country
9.1.2 Latin America Perennial Allergic Rhinitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Perennial Allergic Rhinitis Drug Market Facts & Figures by Type
9.3 Central & South America Perennial Allergic Rhinitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Perennial Allergic Rhinitis Drug by Country
10.1.1 Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country
10.1.2 Middle East and Africa Perennial Allergic Rhinitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Perennial Allergic Rhinitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Perennial Allergic Rhinitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Faes Farma, S.A.
11.1.1 Faes Farma, S.A. Corporation Information
11.1.2 Faes Farma, S.A. Description and Business Overview
11.1.3 Faes Farma, S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Products Offered
11.1.5 Faes Farma, S.A. Related Developments
11.2 Glenmark Pharmaceuticals Ltd.
11.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
11.2.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Products Offered
11.2.5 Glenmark Pharmaceuticals Ltd. Related Developments
11.3 Hisamitsu Pharmaceutical Co., Inc.
11.3.1 Hisamitsu Pharmaceutical Co., Inc. Corporation Information
11.3.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
11.3.3 Hisamitsu Pharmaceutical Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Products Offered
11.3.5 Hisamitsu Pharmaceutical Co., Inc. Related Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Corporation Information
11.4.2 Merck & Co., Inc. Description and Business Overview
11.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Products Offered
11.4.5 Merck & Co., Inc. Related Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Corporation Information
11.5.2 Pfizer Inc. Description and Business Overview
11.5.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Inc. Perennial Allergic Rhinitis Drug Products Offered
11.5.5 Pfizer Inc. Related Developments
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Corporation Information
11.6.2 Shionogi & Co., Ltd. Description and Business Overview
11.6.3 Shionogi & Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Products Offered
11.6.5 Shionogi & Co., Ltd. Related Developments
11.7 VentiRx Pharmaceuticals, Inc.
11.7.1 VentiRx Pharmaceuticals, Inc. Corporation Information
11.7.2 VentiRx Pharmaceuticals, Inc. Description and Business Overview
11.7.3 VentiRx Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Products Offered
11.7.5 VentiRx Pharmaceuticals, Inc. Related Developments
11.1 Faes Farma, S.A.
11.1.1 Faes Farma, S.A. Corporation Information
11.1.2 Faes Farma, S.A. Description and Business Overview
11.1.3 Faes Farma, S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Products Offered
11.1.5 Faes Farma, S.A. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Perennial Allergic Rhinitis Drug Market Estimates and Projections by Region
12.1.1 Global Perennial Allergic Rhinitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Perennial Allergic Rhinitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Perennial Allergic Rhinitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Perennial Allergic Rhinitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Perennial Allergic Rhinitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Perennial Allergic Rhinitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Perennial Allergic Rhinitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Perennial Allergic Rhinitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Perennial Allergic Rhinitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Perennial Allergic Rhinitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Perennial Allergic Rhinitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Perennial Allergic Rhinitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Perennial Allergic Rhinitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Perennial Allergic Rhinitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Perennial Allergic Rhinitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Perennial Allergic Rhinitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Perennial Allergic Rhinitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Perennial Allergic Rhinitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Perennial Allergic Rhinitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Perennial Allergic Rhinitis Drug Market Segments
Table 2. Ranking of Global Top Perennial Allergic Rhinitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Perennial Allergic Rhinitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of APC-3000
Table 5. Major Manufacturers of Asapiprant
Table 6. Major Manufacturers of Bilastine
Table 7. Major Manufacturers of Desloratadine
Table 8. Major Manufacturers of Others
Table 9. Global Perennial Allergic Rhinitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Perennial Allergic Rhinitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Perennial Allergic Rhinitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Perennial Allergic Rhinitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Perennial Allergic Rhinitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Perennial Allergic Rhinitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Perennial Allergic Rhinitis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Perennial Allergic Rhinitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Perennial Allergic Rhinitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Perennial Allergic Rhinitis Drug as of 2019)
Table 18. Perennial Allergic Rhinitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Perennial Allergic Rhinitis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Perennial Allergic Rhinitis Drug Price (2015-2020) (USD/Pcs)
Table 21. Perennial Allergic Rhinitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Perennial Allergic Rhinitis Drug Product Type
Table 23. Date of International Manufacturers Enter into Perennial Allergic Rhinitis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Perennial Allergic Rhinitis Drug Sales Share by Type (2015-2020)
Table 27. Global Perennial Allergic Rhinitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Perennial Allergic Rhinitis Drug Revenue Share by Type (2015-2020)
Table 29. Perennial Allergic Rhinitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Perennial Allergic Rhinitis Drug Sales Share by Application (2015-2020)
Table 32. North America Perennial Allergic Rhinitis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Perennial Allergic Rhinitis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Perennial Allergic Rhinitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Perennial Allergic Rhinitis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Perennial Allergic Rhinitis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Perennial Allergic Rhinitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Perennial Allergic Rhinitis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Perennial Allergic Rhinitis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Perennial Allergic Rhinitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Perennial Allergic Rhinitis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Perennial Allergic Rhinitis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Perennial Allergic Rhinitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Perennial Allergic Rhinitis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Perennial Allergic Rhinitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Table 72. Faes Farma, S.A. Corporation Information
Table 73. Faes Farma, S.A. Description and Major Businesses
Table 74. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Faes Farma, S.A. Product
Table 76. Faes Farma, S.A. Recent Development
Table 77. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 78. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
Table 79. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Glenmark Pharmaceuticals Ltd. Product
Table 81. Glenmark Pharmaceuticals Ltd. Recent Development
Table 82. Hisamitsu Pharmaceutical Co., Inc. Corporation Information
Table 83. Hisamitsu Pharmaceutical Co., Inc. Description and Major Businesses
Table 84. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Hisamitsu Pharmaceutical Co., Inc. Product
Table 86. Hisamitsu Pharmaceutical Co., Inc. Recent Development
Table 87. Merck & Co., Inc. Corporation Information
Table 88. Merck & Co., Inc. Description and Major Businesses
Table 89. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Merck & Co., Inc. Product
Table 91. Merck & Co., Inc. Recent Development
Table 92. Pfizer Inc. Corporation Information
Table 93. Pfizer Inc. Description and Major Businesses
Table 94. Pfizer Inc. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Pfizer Inc. Product
Table 96. Pfizer Inc. Recent Development
Table 97. Shionogi & Co., Ltd. Corporation Information
Table 98. Shionogi & Co., Ltd. Description and Major Businesses
Table 99. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Shionogi & Co., Ltd. Product
Table 101. Shionogi & Co., Ltd. Recent Development
Table 102. VentiRx Pharmaceuticals, Inc. Corporation Information
Table 103. VentiRx Pharmaceuticals, Inc. Description and Major Businesses
Table 104. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. VentiRx Pharmaceuticals, Inc. Product
Table 106. VentiRx Pharmaceuticals, Inc. Recent Development
Table 107. Global Perennial Allergic Rhinitis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Perennial Allergic Rhinitis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Perennial Allergic Rhinitis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Perennial Allergic Rhinitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Perennial Allergic Rhinitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Perennial Allergic Rhinitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Perennial Allergic Rhinitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Perennial Allergic Rhinitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Perennial Allergic Rhinitis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Perennial Allergic Rhinitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Perennial Allergic Rhinitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Perennial Allergic Rhinitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Perennial Allergic Rhinitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Perennial Allergic Rhinitis Drug Players
Table 125. Perennial Allergic Rhinitis Drug Customers List
Table 126. Perennial Allergic Rhinitis Drug Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Perennial Allergic Rhinitis Drug Product Picture
Figure 2. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. APC-3000 Product Picture
Figure 4. Asapiprant Product Picture
Figure 5. Bilastine Product Picture
Figure 6. Desloratadine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Perennial Allergic Rhinitis Drug Report Years Considered
Figure 13. Global Perennial Allergic Rhinitis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Perennial Allergic Rhinitis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Perennial Allergic Rhinitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Perennial Allergic Rhinitis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Perennial Allergic Rhinitis Drug Sales Market Share by Region in 2019
Figure 18. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region in 2019
Figure 20. Global Perennial Allergic Rhinitis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Perennial Allergic Rhinitis Drug Revenue in 2019
Figure 22. Perennial Allergic Rhinitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type in 2019
Figure 25. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type in 2019
Figure 27. Global Perennial Allergic Rhinitis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application in 2019
Figure 30. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application in 2019
Figure 32. North America Perennial Allergic Rhinitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Perennial Allergic Rhinitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Perennial Allergic Rhinitis Drug Sales Market Share by Country in 2019
Figure 35. North America Perennial Allergic Rhinitis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Perennial Allergic Rhinitis Drug Market Share by Type in 2019
Figure 41. North America Perennial Allergic Rhinitis Drug Market Share by Application in 2019
Figure 42. Europe Perennial Allergic Rhinitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Perennial Allergic Rhinitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Country in 2019
Figure 45. Europe Perennial Allergic Rhinitis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Perennial Allergic Rhinitis Drug Market Share by Type in 2019
Figure 57. Europe Perennial Allergic Rhinitis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Perennial Allergic Rhinitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Perennial Allergic Rhinitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Perennial Allergic Rhinitis Drug Revenue Market Share by Region in 2019
Figure 62. China Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Perennial Allergic Rhinitis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Perennial Allergic Rhinitis Drug Market Share by Application in 2019
Figure 86. Latin America Perennial Allergic Rhinitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Perennial Allergic Rhinitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Perennial Allergic Rhinitis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Perennial Allergic Rhinitis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Perennial Allergic Rhinitis Drug Market Share by Type in 2019
Figure 97. Latin America Perennial Allergic Rhinitis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Perennial Allergic Rhinitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Perennial Allergic Rhinitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Perennial Allergic Rhinitis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Perennial Allergic Rhinitis Drug Market Share by Application in 2019
Figure 110. North America Perennial Allergic Rhinitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Perennial Allergic Rhinitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Perennial Allergic Rhinitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Perennial Allergic Rhinitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Perennial Allergic Rhinitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Perennial Allergic Rhinitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Perennial Allergic Rhinitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Perennial Allergic Rhinitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
多年生アレルギー性鼻炎の世界市場（～2026年） Market Analysis and Insights: Global Perennial Allergic Rhinitis Market The global Perennial Allergic Rhinitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Perennial Allergic Rhinitis Scope and Market Size Perennial…- アレルギー性鼻炎治療の世界市場（～2026年） The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with this other symptoms includes running nose, sneezing, watery eyes, problem during smelling, cough and sore th…
- アレルギー性結膜炎薬の世界市場（～2026年） Market Analysis and Insights: Global Allergic Conjunctivitis Drug Market The global Allergic Conjunctivitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Allergic Conjunctivitis Drug Scope and Market Size Allerg…
- アレルギー性結膜炎の世界市場（～2026年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…
- 経鼻ドラッグデリバリーの世界市場（～2026年） Nasal Drug Delivery is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acti…